Logo image of CXT

CRANE NXT CO (CXT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CXT - US2244411052 - Common Stock

49.41 USD
+1.25 (+2.6%)
Last: 1/8/2026, 8:04:00 PM
49.41 USD
0 (0%)
After Hours: 1/8/2026, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CXT. CXT was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. While CXT has a great profitability rating, there are quite some concerns on its financial health. CXT is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CXT had positive earnings in the past year.
In the past year CXT had a positive cash flow from operations.
In the past 5 years CXT has always been profitable.
In the past 5 years CXT always reported a positive cash flow from operatings.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.30%, CXT is in the better half of the industry, outperforming 71.77% of the companies in the same industry.
With a decent Return On Equity value of 12.74%, CXT is doing good in the industry, outperforming 79.84% of the companies in the same industry.
CXT has a Return On Invested Capital of 8.69%. This is in the better half of the industry: CXT outperforms 78.23% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CXT is above the industry average of 9.00%.
The last Return On Invested Capital (8.69%) for CXT is well below the 3 year average (13.27%), which needs to be investigated, but indicates that CXT had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROIC 8.69%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

CXT's Profit Margin of 9.80% is amongst the best of the industry. CXT outperforms 82.26% of its industry peers.
CXT's Profit Margin has declined in the last couple of years.
CXT has a Operating Margin of 17.59%. This is amongst the best in the industry. CXT outperforms 92.74% of its industry peers.
In the last couple of years the Operating Margin of CXT has remained more or less at the same level.
CXT's Gross Margin of 43.20% is fine compared to the rest of the industry. CXT outperforms 75.00% of its industry peers.
CXT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

CXT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CXT has more shares outstanding
CXT has a worse debt/assets ratio than last year.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.06 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.06, CXT is doing worse than 69.35% of the companies in the same industry.
CXT has a debt to FCF ratio of 6.27. This is a slightly negative value and a sign of low solvency as CXT would need 6.27 years to pay back of all of its debts.
The Debt to FCF ratio of CXT (6.27) is comparable to the rest of the industry.
CXT has a Debt/Equity ratio of 0.89. This is a neutral value indicating CXT is somewhat dependend on debt financing.
CXT has a Debt to Equity ratio of 0.89. This is amonst the worse of the industry: CXT underperforms 87.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Altman-Z 2.06
ROIC/WACC0.93
WACC9.35%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CXT has a Current Ratio of 1.26. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
CXT has a worse Current ratio (1.26) than 81.45% of its industry peers.
A Quick Ratio of 0.94 indicates that CXT may have some problems paying its short term obligations.
With a Quick ratio value of 0.94, CXT is not doing good in the industry: 81.45% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CXT have decreased by -1.72% in the last year.
Measured over the past years, CXT shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.61% on average per year.
Looking at the last year, CXT shows a quite strong growth in Revenue. The Revenue has grown by 9.30% in the last year.
The Revenue has been growing slightly by 3.39% on average over the past years.
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%

3.2 Future

CXT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.04% yearly.
Based on estimates for the next years, CXT will show a small growth in Revenue. The Revenue will grow by 7.20% on average per year.
EPS Next Y-4.27%
EPS Next 2Y3.38%
EPS Next 3Y7.04%
EPS Next 5YN/A
Revenue Next Year9.22%
Revenue Next 2Y7.97%
Revenue Next 3Y7.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.38 indicates a correct valuation of CXT.
Based on the Price/Earnings ratio, CXT is valued cheaper than 91.13% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.00. CXT is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 10.83, the valuation of CXT can be described as very reasonable.
CXT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CXT is cheaper than 91.13% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.70. CXT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.38
Fwd PE 10.83
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CXT is valued cheaply inside the industry as 90.32% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CXT is valued cheaply inside the industry as 88.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.44
EV/EBITDA 9.02
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CXT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.38%
EPS Next 3Y7.04%

5

5. Dividend

5.1 Amount

CXT has a Yearly Dividend Yield of 1.44%.
The stock price of CXT dropped by -24.65% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CXT's Dividend Yield is rather good when compared to the industry average which is at 0.47. CXT pays more dividend than 91.94% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 1.94, CXT is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.44%

5.2 History

On average, the dividend of CXT grows each year by 6.42%, which is quite nice.
CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CXT pays out 24.82% of its income as dividend. This is a sustainable payout ratio.
CXT's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP24.82%
EPS Next 2Y3.38%
EPS Next 3Y7.04%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (1/8/2026, 8:04:00 PM)

After market: 49.41 0 (0%)

49.41

+1.25 (+2.6%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners114.42%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change1.75%
Market Cap2.84B
Revenue(TTM)1.58B
Net Income(TTM)154.70M
Analysts81.82
Price Target94.28 (90.81%)
Short Float %12.54%
Short Ratio12
Dividend
Industry RankSector Rank
Dividend Yield 1.44%
Yearly Dividend0.64
Dividend Growth(5Y)6.42%
DP24.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.72%
Min EPS beat(2)0.03%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)1.08%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)6.53%
EPS beat(16)13
Avg EPS beat(16)6.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)0.73%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.92%
PT rev (3m)2.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.54%
Valuation
Industry RankSector Rank
PE 12.38
Fwd PE 10.83
P/S 1.8
P/FCF 16.44
P/OCF 13.09
P/B 2.34
P/tB N/A
EV/EBITDA 9.02
EPS(TTM)3.99
EY8.08%
EPS(NY)4.56
Fwd EY9.24%
FCF(TTM)3.01
FCFY6.08%
OCF(TTM)3.78
OCFY7.64%
SpS27.5
BVpS21.14
TBVpS-9.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number43.57
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROCE 12.04%
ROIC 8.69%
ROICexc 9.36%
ROICexgc 34.76%
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
FCFM 10.93%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
ROICexc(3y)14.97%
ROICexc(5y)11.69%
ROICexgc(3y)57.83%
ROICexgc(5y)41.66%
ROCE(3y)18.35%
ROCE(5y)14.1%
ROICexgc growth 3Y39.7%
ROICexgc growth 5YN/A
ROICexc growth 3Y25.58%
ROICexc growth 5YN/A
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Debt/EBITDA 2.86
Cap/Depr 43.72%
Cap/Sales 2.8%
Interest Coverage 5.31
Cash Conversion 57.22%
Profit Quality 111.57%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.06
F-Score3
WACC9.35%
ROIC/WACC0.93
Cap/Depr(3y)39.82%
Cap/Depr(5y)33.75%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.89%
Profit Quality(3y)120.27%
Profit Quality(5y)131.76%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
EPS Next Y-4.27%
EPS Next 2Y3.38%
EPS Next 3Y7.04%
EPS Next 5YN/A
Revenue 1Y (TTM)9.3%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%
Revenue Next Year9.22%
Revenue Next 2Y7.97%
Revenue Next 3Y7.2%
Revenue Next 5YN/A
EBIT growth 1Y-0.68%
EBIT growth 3Y4.76%
EBIT growth 5YN/A
EBIT Next Year18.99%
EBIT Next 3Y13.2%
EBIT Next 5YN/A
FCF growth 1Y-55.34%
FCF growth 3Y-13.25%
FCF growth 5YN/A
OCF growth 1Y-48.89%
OCF growth 3Y-8.23%
OCF growth 5YN/A

CRANE NXT CO / CXT FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 7 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 7 / 10.


How financially healthy is CRANE NXT CO?

The financial health rating of CRANE NXT CO (CXT) is 2 / 10.


Is the dividend of CRANE NXT CO sustainable?

The dividend rating of CRANE NXT CO (CXT) is 5 / 10 and the dividend payout ratio is 24.82%.